Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Gastrointest Endosc. 2020 Jan 31;92(1):78–87.e2. doi: 10.1016/j.gie.2020.01.037

Table 3. Complete responder scenarios.

Four patient scenarios, and six interventions per scenario considered for complete PPI responders. Rankings from the entire group, surgeon subset and therapeutic GI (iGI) subset are displayed. Each cell displays ranking for appropriateness [% agreement, median (min-max)]. Cells shaded green indicate agreement as an appropriate intervention, red indicate agreement as an inappropriate intervention, and white indicate lack of agreement and/or uncertain appropriateness.

Scenario All Experts Surgeons Subset iGI Subset
OMT LF MSA TIF TIFCR RFED OMT LF MSA TIF TIFCR RFED OMT LF MSA TIF TIFCR RFED
Heartburn,
+ Sig Hernia
60%, 7
(1-9)
100%, 9
(7-9)
100%, 9
(7-9)
0%, 1
(1-2)
60%, 7
(1-9)
0%, 1
(1-1)
50%, 6.5
(1-9)
100%, 9
(9-9)
100%, 9
(7-9)
0%, 1
(1-8)
38%, 5.5
(1-8)
0%, 1
(1-1)
71%, 7
(5-9)
100%, 9
(7-9)
100%, 8
(7-9)
0%, 1
(1-2)
86%, 7
(5-9)
0%, 1
(1-1)
Regurigtation,
+ Sig Hernia
40%, 5
(1-9)
100%, 9
(9-9)
100%, 9
(7-9)
0%, 1
(1-2)
60%, 7
(1-9)
0%, 1
(1-1)
25%, 5
(1-9)
100%, 9
(9-9)
100%, 9
(7-9)
0%, 1
(1-1)
38%, 5.5
(1-8)
0%, 1
(1-1)
57%, 7
(1-9)
100%, 9
(9-9)
100%, 9
(8-9)
0%, 1
(1-2)
86%, 7
(3-9)
0%, 1
(1-1)
Heartburn,
No Sig Hernia
100%, 9
(7-9)
93%, 9
(6-9)
100%, 8
(7-9)
87%, 8
(6-9)
40%, 6
(1-9)
40%, 6
(2-9)
100%, 9
(8-9)
100%, 9
(7-9)
100%, 9
(7-9)
75%, 7.5
(6-9)
50%, 6.5
(1-8)
25%, 6
(3-9)
100%, 8
(7-9)
86%, 7
(6-9)
100%, 7
(7-9)
100%, 8
(7-9)
29%, 5
(1-9)
57%, 7
(2-9)
Regurgitations,
No Sig Hernia
60%, 9
(2-9)
87%, 9
(6-9)
93%, 9
(6-9)
80%, 8
(6-9)
40%, 6
(1-8)
33%, 6
(1-8)
63%, 9
(4-9)
100%, 9
(7-9)
100%, 9
(7-9)
75%, 7.5
(6-9)
50%, 6.5
(1-8)
25%, 6
(1-8)
57%, 8
(2-9)
71%, 8
(6-9)
86%, 7
(6-9)
867%, 8
(6-9)
29%, 5
(1-8)
43%, 5
(1-8)

Optimization of medical therapy (OMT); Laparoscopic fundoplication (LF); Magnetic sphincter augmentation (MSA); Transoral incisionless fundoplication (TIF); TIF with crural repair (TIFCR); Radiofrequency energy delivery (RFED)